Rashmee Patil, MD

Biography

Dr. Patil completed her Internal Medicine Residency at New York University - Brooklyn and her Fellowship in Hepatology and Liver Transplantation at Baylor College of Medicine in Houston, Texas. In 2018, she shifted from a general Hepatology clinical practice to a focus on building and scaling a MASH clinical research program. She is the Founder of South Texas Research Institute (STRI), the premier private clinical research site network originating in the Rio Grande Valley of Texas. Beginning as one site and five employees in 2020, STRI grew to 2 locations and over 30 team members in 2022. STRI partnered with Pinnacle Clinical Research in 2022, and she served as CEO of the combined entity from 2022-2024. During this time, Pinnacle grew from 5 to 13 locations and expanded its geographic reach outside of Texas. In late 2024, she stepped into the role of Chief Medical Officer and is leading the organization's physician/investigator teams through the next phase of growth and transformation.

As a clinician, her focus is on MASLD/MASH, non-invasive testing, preventative Hepatology, creating care pathways, and improving racial/socioeconomic disparities in liver disease. As a clinical trialist, her focus is on building a physician community of investigators and improving awareness about this career path, increasing accessibility to clinical trials for patients living outside of the boundaries of academic centers, and improving site-Sponsor relationships. She has served as a Principal Investigator on over 60 clinical trials in MASH/Obesity/CV outcomes and has published in prestigious journals such as Hepatology, Lancet, NEJM, and Nature.